Deal of the Day — limited-time pharmacy picks!
Sunitinib 50mg Capsule

Sunitinib 50mg Capsule

Prescription requiredRx Required

Salt Composition: Sunitinib

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

28 capsules in Bottle

About The Product

Kidney Cancer and Gastrointestinal Stromal Tumor

Sunitinib 50 mg Capsule is a cancer-fighting medicine as it belongs to the antineoplastic agents group of medicine. The doctor prescribes this medicine to treat Gastrointestinal stromal cancer, kidney cancer, and pancreatic neuroendocrine tumors. Sunitinib 50mg Capsule is a small molecule that inhibits the action of multiple Receptor Tyrosine Kinase (RTKs), some of which are connected to tumor growth, pathological angiogenesis, and metastatic progression of cancer. After the oral administration, the effect of this capsule can be observed within 6 to 12 hours.

Side Effects

  • Sunitinib 50mg Capsule may cause some adverse impact on the body during the treatment, and most of them resolve on their own.
  • Some common side effects include: Blurred vision Cough Nausea Weakness Rash Fever Abdominal pain High blood pressure Stomatitis Back pain Taste change Weight loss Indigestion Bleeding gums Thyroid imbalances Loss of appetite Constipation Contact a doctor immediately if you experience any serious or persistent side effects.

How To Use

  • Take this medicine as prescribed by your doctor.
  • Sunitinib 50 mg Capsule may be taken with or without food, but it is better to take it at a fixed time every day to get effective results.
  • Swallow the capsule as a whole with a glass of water and don't open, crush, or dissolve it.

Safety Advice

Alcohol

Avoid the consumption of alcohol while taking Sunitinib 50 mg Capsule, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms.

Pregnancy

Pregnancy: Sunitinib 50 mg Capsule is not recommended during pregnancy as it is unsafe for the developing fetus.

Breast Feeding

Breastfeeding women should discuss the potential risks and benefits of the Sunitinib 50 mg Capsule with their healthcare provider before starting treatment.

Driving

Patients should avoid driving or operating machinery while taking this medicine if they experience side effects such as fatigue, dizziness, or blurred vision

Kidney

Avoid the consumption of this medicine before consulting a doctor if you have any kidney-related issues.

Liver

Avoid Sunitinib 50 mg Capsule consumption if you have any liver-related issues because this medicine causes liver toxicity, which can make your condition worse.

Missed Doses

  • It is advisable not to miss a dose.
  • If you miss a scheduled dose of Sunitinib 50mg Capsule, contact your doctor immediately.

FAQs

Sunitinib 50 mg capsule is an anti-cancer medication, which is used in the treatment of Kidney cancer, pancreatic neuroendocrine tumors, and Gastrointestinal Stromal Tumors.

This medication interferes with the growth of cancer cells and destroys

Reference

1. Chouhan, J. D., Zamarripa, D. E., Lai, P. H., Oramasionwu, C. U., & Grabinski, J. L. (2007). Sunitinib (Sutent®): A novel agent for the treatment of metastatic renal cell carcinoma. Journal of Oncology Pharmacy Practice, 13(1), 5-15.

2. Navid, F., Christensen, R., Minkin, P., Stewart, C. F., Furman, W. L., & Baker, S. (2008). Stability of sunitinib in oral suspension. Annals of Pharmacotherapy, 42(7-8), 962-966.

3. Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., ... & Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. The Lancet, 368(9544), 1329-1338.

4.https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021938s13s17s18lbl.pdf

5. Blumenthal, G. M., Cortazar, P., Zhang, J. J., Tang, S., Sridhara, R., Murgo, A., ... & Pazdur, R. (2012). FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors. The oncologist, 17(8), 1108-1113.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026